Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
26,700
Employees26,700
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
26,700
Employees26,700

AMGN Key Statistics

Market cap
167.65B
Market cap167.65B
Price-Earnings ratio
44.68
Price-Earnings ratio44.68
Dividend yield
2.77%
Dividend yield2.77%
Average volume
2.66M
Average volume2.66M
High today
$316.33
High today$316.33
Low today
$310.38
Low today$310.38
Open price
$315.00
Open price$315.00
Volume
1.97M
Volume1.97M
52 Week high
$329.72
52 Week high$329.72
52 Week low
$211.71
52 Week low$211.71

AMGN News

Benzinga 2d
Amgen Unusual Options Activity - Amgen - Benzinga

Loading... Loading... Investors with a lot of money to spend have taken a bullish stance on Amgen AMGN. And retail traders should know. We noticed this today...

Amgen Unusual Options Activity - Amgen - Benzinga
Yahoo Finance 3d
Amgen's Tarlatamab Receives FDA Approval for SCLC - Yahoo Finance

Amgen AMGN announced that the FDA has granted accelerated approval to tarlatamab for pre-treated advanced small cell lung cancer (ES-SCLC). Tarlatamab is a del...

Amgen's Tarlatamab Receives FDA Approval for SCLC - Yahoo Finance
Yahoo Finance 3d
FDA approves Amgen drug for tough-to-treat form of lung cancer - Yahoo Finance

Dive Brief: The Food and Drug Administration on Thursday granted accelerated approval to a new dual-acting drug from Amgen to treat small cell lung cancer in p...

FDA approves Amgen drug for tough-to-treat form of lung cancer - Yahoo Finance

Analyst ratings

50%

of 30 ratings
Buy
50%
Hold
43.3%
Sell
6.7%

More AMGN News

TipRanks 3d
U.S. FDA Approves Amgen's Imdelltra - TipRanks.com - TipRanks

The U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) Imdelltra (tarlatamab-dlle) therapy for extensive-stage small cell lung cancer (E...

New York Times 3d
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer - The New York Times

The Food and Drug Administration on Thursday approved an innovative new treatment for patients with a form of lung cancer. It is to be used only by patients who...

F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer - The New York Times
CNBC 3d
FDA approves Amgen's treatment for most deadly form of lung cancer

The Food and Drug Administration on Thursday approved Amgen 's therapy for patients with the most deadly form of lung cancer. The agency cleared the drug, whic...

FDA approves Amgen's treatment for most deadly form of lung cancer
Seeking Alpha 3d
Amgen wins FDA nod for new lung cancer therapy

The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen’s (NASDAQ:AMGN) targeted cancer therapy, Imdelltra, as a late-line option for adults with...

Amgen wins FDA nod for new lung cancer therapy
Yahoo Finance 4d
Amgen Inc. Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the nea...

Amgen Inc. Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Investor's Business Daily 4d
Stocks To Watch: Amgen Sees RS Rating Jump To 81 - Investor's Business Daily

The Relative Strength (RS) Rating for Amgen (AMGN) climbed into a new percentile Thursday, with an increase from 77 to 81. X This exclusive rating from Investo...

Stocks To Watch: Amgen Sees RS Rating Jump To 81 - Investor's Business Daily
Benzinga 4d
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally - Amgen - Benzinga

Loading... Loading... The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflati...

S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally - Amgen - Benzinga
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.